After Pfizer skipped animal trials for their new mRNA coronavirus vaccine, they began using various doses of foreign mRNA to experiment on human test subjects. This foreign vaccine mRNA stops the innate transcription process in human cells, providing new instructions for protein synthesis which basically overwrites the innate genetic expression from the body’s own DNA.
The foreign vaccine mRNA halts the natural protein synthesis in human cells, blocking cells from producing the amino acid sequences that they typically build for the proteins that are needed in the body. The foreign vaccine mRNA circumvents the innate intelligence of the human body, instructing the ribosomes of the cells to instead churn out spike proteins (properties from the coronavirus bio-weapon).
In the study design documents furnished by Pfizer, scientists warn of “occupational exposure” to the vaccinated in a 24-hour monitoring period. What might be transmitted by the vaccinated, if occupational exposure is of concern? Why did Pfizer keep this limited occupational exposure data separate from the clinical study?
Pfizer documents warn of potential adverse events from occupational exposure to the vaccinated
According to Pfizer’s own study design documents, scientists were concerned about “occupational exposure” to the recently vaccinated test subjects. Under section “18.104.22.168. Occupational Exposure” Pfizer warns that caretakers and close contacts of the recently vaccinated could be exposed to the spike proteins that are translated and synthesized in the cells of the vaccinated. During the clinical trials, Pfizer instructed researchers to monitor for severe adverse events in the vaccinated and in the unvaccinated people who were exposed to the vaccinated. What does “occupational exposure” entail? The mRNA vaccines do not shed live viruses, so what exactly is being transmitted from the vaccinated to the unvaccinated?
“When such exposures happen, the investigator must report them to Pfizer safety within 24 hours of becoming aware of when they happened, regardless of whether or not there is an associated secondary adverse event. However, Pfizer said the information does not pertain to the participant involved in the study, so it can be “kept separate from the study.”